Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

255 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Alcohol consumption and risk of multiple myeloma in the NIH-AARP Diet and Health Study.
Santo L, Liao LM, Andreotti G, Purdue MP, Hofmann JN. Santo L, et al. Int J Cancer. 2019 Jan 1;144(1):43-48. doi: 10.1002/ijc.31648. Epub 2018 Oct 30. Int J Cancer. 2019. PMID: 29971781
Bone Disease in Multiple Myeloma.
Eda H, Santo L, David Roodman G, Raje N. Eda H, et al. Among authors: santo l. Cancer Treat Res. 2016;169:251-270. doi: 10.1007/978-3-319-40320-5_14. Cancer Treat Res. 2016. PMID: 27696267 Review.
Role of decorin in multiple myeloma (MM) bone marrow microenvironment.
Nemani N, Santo L, Eda H, Cirstea D, Mishima Y, Patel C, O'Donnell E, Yee A, Raje N. Nemani N, et al. Among authors: santo l. J Bone Miner Res. 2015 Mar;30(3):465-70. doi: 10.1002/jbmr.2371. J Bone Miner Res. 2015. PMID: 25407518
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma.
Cirstea D, Santo L, Hideshima T, Eda H, Mishima Y, Nemani N, Mahindra A, Yee A, Gorgun G, Hu Y, Ohguchi H, Suzuki R, Cottini F, Guichard SM, Anderson KC, Raje N. Cirstea D, et al. Among authors: santo l. Mol Cancer Ther. 2014 Nov;13(11):2489-500. doi: 10.1158/1535-7163.MCT-14-0147. Epub 2014 Aug 29. Mol Cancer Ther. 2014. PMID: 25172964
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.
Patel CG, Yee AJ, Scullen TA, Nemani N, Santo L, Richardson PG, Laubach JP, Ghobrial IM, Schlossman RL, Munshi NC, Anderson KC, Raje NS. Patel CG, et al. Among authors: santo l. Clin Cancer Res. 2014 Aug 1;20(15):3955-61. doi: 10.1158/1078-0432.CCR-14-0434. Epub 2014 Jun 23. Clin Cancer Res. 2014. PMID: 24958808
In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma.
Pozzi S, Fulciniti M, Yan H, Vallet S, Eda H, Patel K, Santo L, Cirstea D, Hideshima T, Schirtzinge L, Kuhstoss S, Anderson KC, Munshi N, Scadden D, Kronenberg HM, Raje N. Pozzi S, et al. Among authors: santo l. Bone. 2013 Apr;53(2):487-96. doi: 10.1016/j.bone.2013.01.012. Epub 2013 Jan 17. Bone. 2013. PMID: 23333523 Free PMC article.
Cyclin dependent kinases in cancer: potential for therapeutic intervention.
Canavese M, Santo L, Raje N. Canavese M, et al. Among authors: santo l. Cancer Biol Ther. 2012 May;13(7):451-7. doi: 10.4161/cbt.19589. Epub 2012 May 1. Cancer Biol Ther. 2012. PMID: 22361734 Review.
Circulating resistin levels and risk of multiple myeloma in three prospective cohorts.
Santo L, Teras LR, Giles GG, Weinstein SJ, Albanes D, Wang Y, Pfeiffer RM, Lan Q, Rothman N, Birmann BM, Colditz GA, Pollak MN, Purdue MP, Hofmann JN. Santo L, et al. Br J Cancer. 2017 Oct 10;117(8):1241-1245. doi: 10.1038/bjc.2017.282. Epub 2017 Aug 22. Br J Cancer. 2017. PMID: 28829767 Free PMC article.
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Landgren O, Hofmann JN, McShane CM, Santo L, Hultcrantz M, Korde N, Mailankody S, Kazandjian D, Murata K, Thoren K, Ramanathan L, Dogan A, Rustad E, Lu SX, Akhlaghi T, Kristinsson SY, Björkholm M, Devlin S, Purdue MP, Pfeiffer RM, Turesson I. Landgren O, et al. Among authors: santo l. JAMA Oncol. 2019 Jul 18;5(9):1293-301. doi: 10.1001/jamaoncol.2019.1568. Online ahead of print. JAMA Oncol. 2019. PMID: 31318385 Free PMC article.
Pim2 is important for regulating DNA damage response in multiple myeloma cells.
Ramachandran J, Santo L, Siu KT, Panaroni C, Raje N. Ramachandran J, et al. Among authors: santo l. Blood Cancer J. 2016 Aug 26;6(8):e462. doi: 10.1038/bcj.2016.73. Blood Cancer J. 2016. PMID: 27564460 Free PMC article.
255 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page